Guardian Pharmacy Services, Inc.
GRDN
$20.33
-$0.57-2.73%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.57% | 20.46% | 19.66% | 18.39% | 10.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.57% | 20.46% | 19.66% | 18.39% | 10.63% |
| Cost of Revenue | 20.27% | 19.86% | 20.41% | 17.54% | 11.42% |
| Gross Profit | 16.78% | 22.95% | 16.64% | 21.79% | 7.58% |
| SG&A Expenses | 14.28% | 194.24% | 182.78% | 76.94% | -0.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.26% | 31.10% | 55.72% | 24.06% | 9.28% |
| Operating Income | 27.53% | -45.62% | -1,552.65% | -32.77% | 61.53% |
| Income Before Tax | 204.15% | 11.42% | -1,410.24% | -35.16% | -24.59% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 115.20% | -18.67% | -1,412.75% | -35.16% | -24.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 104.06% | 104.01% | -58.86% | -75.77% | -7.46% |
| Net Income | -- | -0.62% | -897.70% | -50.52% | -100.00% |
| EBIT | 27.53% | -45.62% | -1,552.65% | -32.77% | 61.53% |
| EBITDA | 22.31% | -39.69% | -5,787.65% | -26.59% | 39.08% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | 0.81% | -- | -- |